HCA Healthcare Inc. Common Stock (HCA)
Stock · NYSE · Health Care
$458.68as of 10/16/2026
Price chart
Active signals
HCA Signal Track Record
How signals performed across all stocks →What HCA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 32 | +0.3% | 53% | September 18, 2026 |
| Bollinger Band Breakout | 29 | +3.5% | 69% | October 8, 2026 |
| Bollinger Band Breakdown | 21 | -1.7% | 43% | July 14, 2026 |
| 200-Day Moving Average TouchActive now | 7 | +8.1% | 57% | October 8, 2026 |
| Any 20-session window (baseline) | +2.1% | 60% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HCA
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, o…
- Sector
- Health Care
- Industry
- Hospital/Nursing Management
- Employees
- 230,000
- Website
- hcahealthcare.com/
Fundamentals
- 1-day range
- $467.29$478.82
- Market cap
- $88.53B
- P/E (trailing)
- 14.83
- P/E (forward)
- 14.64
- EPS (trailing)
- $29.87
- Dividend yield
- 0.95%
- Beta
- 1.12
- Avg. volume
- 1.36M
- Ex-dividend date
- September 16, 2026
- Dividend pay date
- September 30, 2026
How HCA Healthcare Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 10, 2026 · via SEC EDGAR / Finnhub
Forecasts
22 analyst ratings
HCA Healthcare Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HCAHCA Healthcare Inc. Common Stock$458.84▼ 2.06%Market cap $88.53BP/E 14.83$353.99$556.52
- THCTenet Healthcare Corporation Common Stock$267.25▼ 2.86%Market cap $20.66BP/E 9.77$157.58$283.05
- EHCEncompass Health Corporation Common Stock$127.87▲ 0.08%Market cap $12.38BP/E 20.06$92.77$127.99
- ENSGThe Ensign Group Inc. Common Stock$176.63▼ 0.83%Market cap $10.59BP/E 27.51$141.58$218
- UHSUniversal Health Services Inc. Common Stock$185.1▼ 1.21%Market cap $10.27BP/E 7.27$140.08$246.33
- PACSPACS Group Inc. Common Stock$46.91▼ 1.76%Market cap $7.39BP/E 28.09$10.31$49.49
- BKDBrookdale Senior Living Inc. Common Stock$10.09▲ 0.00%Market cap $3.43BP/E —$8.02$17.09
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HCA HCA Healthcare Inc. Common Stock | $88.53B | 14.83 | $458.84 | ▼ 2.06% | $353.99$556.52 |
| THC Tenet Healthcare Corporation Common Stock | $20.66B | 9.77 | $267.25 | ▼ 2.86% | $157.58$283.05 |
| EHC Encompass Health Corporation Common Stock | $12.38B | 20.06 | $127.87 | ▲ 0.08% | $92.77$127.99 |
| ENSG The Ensign Group Inc. Common Stock | $10.59B | 27.51 | $176.63 | ▼ 0.83% | $141.58$218 |
| UHS Universal Health Services Inc. Common Stock | $10.27B | 7.27 | $185.1 | ▼ 1.21% | $140.08$246.33 |
| PACS PACS Group Inc. Common Stock | $7.39B | 28.09 | $46.91 | ▼ 1.76% | $10.31$49.49 |
| BKD Brookdale Senior Living Inc. Common Stock | $3.43B | — | $10.09 | ▲ 0.00% | $8.02$17.09 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- HCA Healthcare (HCA) Could Be 3% Undervalued As Breast Imaging Expansion ContinuesYahoo · 10/7/2026
- RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496Benzinga · 10/7/2026
- Knowtion Health Names Steven Huddleston Chief Executive OfficerYahoo · 10/6/2026
- HCA Healthcare's Q3 2026 Earnings: What to ExpectYahoo · 10/6/2026
- FTC Issues Letters Warning Hospitals Against Deceptive Pricing Practicesbenzinga · 10/5/2026
- FTC Issues Letters Warning Hospitals Against Deceptive Pricing PracticesBenzinga · 10/5/2026
- 1 Unpopular Stock That Deserves a Second Chance and 2 We QuestionYahoo · 10/5/2026
- Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?Yahoo · 9/30/2026
- HCA Healthcare Presents 2026 Awards of DistinctionYahoo · 9/29/2026
Insider Activity
Insider Actions →- McAlevey Michael R · August 26, 2026 · J7.8K @ $429
- Marks Mike A · May 7, 2026 · Gift3.3K
- Smith Andrea B · April 28, 2026 · Grant509
- Frist William R · April 28, 2026 · Grant809
- Riley Wayne Joseph · April 28, 2026 · Grant509
- Hugh F. Johnston · April 28, 2026 · Grant809
- FRIST THOMAS F III · April 28, 2026 · Grant1.0K
- MICHELSON MICHAEL W · April 28, 2026 · Grant925
- DEPARLE NANCY ANN · April 28, 2026 · Grant509
- John Chidsey · April 28, 2026 · Grant809
Institutional Ownership
March 31, 2026
- Total shares held
- 125.48M
- Total value held
- $57.27B
- Institutional holders
- 1398
- Unknown13.36M
- Unknown10.18M
- Unknown8.96M
- Unknown7.54M
- Unknown4.40M
- Unknown3.91M
- Unknown3.69M
- Unknown3.25M
- Unknown3.03M
- Unknown2.29M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HCA Q2 Earnings and Analyst Optimism Amid Valuation Concerns
HCA Healthcare reported strong Q2 earnings compared to other hospital chains, prompting TD Cowen to raise its price target to $460. While some analysts note the stock could trade at a discount following a 96% run, others argue its strong outpatient partnerships and financial health make it too healthy to downgrade. The company's solid performance continues to draw attention from major market lists and value stock screens.
HCA Q2 Earnings and Analyst Optimism Amid Valuation Concerns. HCA Healthcare reported strong Q2 earnings compared to other hospital chains, prompting TD Cowen to raise its price target to $460. While some analysts note the stock could trade at a discount following a 96% run, others argue its strong outpatient partnerships and financial health make it too healthy to downgrade. The company's solid performance continues to draw attention from major market lists and value stock screens.